GLP-1 analogue fusion protein (Jiangsu T-mab BioPharma)
重组人胰高血糖素样肽-1类似物融合蛋白（酵母，泰康生物）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameGLP-1 analogue fusion protein (Jiangsu T-mab BioPharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu T-Mab Bio-Pharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesJiangsu T-Mab Bio-Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A